- Medical Management of Drug-Resistant Tuberculosis
-
Jeon D
- KMID: 2320639
- Tuberc Respir Dis.
- 2015 Jul;78(3):168-174.
- doi: 10.4046/trd.2015.78.3.168
Drug-resistant tuberculosis (TB) is still a major threat worldwide. However, recent scientific advances in diagnostic and therapeutic tools have improved the management of drug-resistant TB. The development of rapid molecular... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of drug-resistant tuberculosis and its treatment
-
Yim JJ
- KMID: 2258566
- Korean J Med.
- 2009 Aug;77(2):152-156.
Drug-resistant tuberculosis (TB), especially multidrug-resistant (MDR)-TB and extensively drug resistant (XDR)-TB, poses a serious threat to global health because it requires treatment for a long duration and frequent hospitalization, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Extensively Drug Resistant-Tuberculosis, XDR-TB
-
Park JS
- KMID: 2185734
- J Korean Med Assoc.
- 2008 Feb;51(2):168-175.
- doi: 10.5124/jkma.2008.51.2.168
Multidrug-resistant tuberculosis(MDR-TB), resistant to at least the two main TB drugsisoniazid and rifampicin, has been a threat to TB control because the treatment requires more toxic drugs and longer period... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
-
Kim CK, Shin SY, Kim HJ, Lee K
- KMID: 2376789
- Ann Lab Med.
- 2017 Jul;37(4):323-326.
- doi: 10.3343/alm.2017.37.4.323
We aimed to analyze the drug resistance patterns of multidrug-resistant and extensively drug-resistant tuberculosis (TB) and the difference of drug resistance among various settings for health care in Korea. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
-
Shim TS, Jo KW
- KMID: 2170440
- Infect Chemother.
- 2013 Dec;45(4):367-374.
- doi: 10.3947/ic.2013.45.4.367
Treatment of multidrug-resistant tuberculosis (MDR-TB) is challenging because of the high toxicity of second-line drugs and the longer treatment duration required compared with drug-susceptible TB. The efficacy of treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- Trend of Multidrug and Extensively Drug Resistant Tuberculosis in a Tuberculosis Referral Hospital, 2001~2005
-
Jeon D, Shin D, Kang H, Sung N, Kweon K, Shin E, Kim K, Lee M, Park S
- KMID: 1478179
- Tuberc Respir Dis.
- 2008 Mar;64(3):187-193.
- doi: 10.4046/trd.2008.64.3.187
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) are serious threats to worldwide tuberculosis control, but the national burden and the trends of infectious spread are largely unknown. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
-
Yew WW, Koh WJ
- KMID: 2373768
- Korean J Intern Med.
- 2016 Jan;31(1):15-29.
- doi: 10.3904/kjim.2016.31.1.15
A worsening scenario of drug-resistant tuberculosis has increased the need for new treatment strategies to tackle this worldwide emergency. There is a pressing need to simplify and shorten the current... -
- CITED
-
- Close
- SHARE
-
- Close
- Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
-
Yang JS, Kim KJ, Choi H, Lee SH
- KMID: 2429122
- Ann Lab Med.
- 2018 Nov;38(6):563-568.
- doi: 10.3343/alm.2018.38.6.563
BACKGROUND: Delamanid, bedaquiline, and linezolid have recently been approved for the treatment of multidrug- and extensively drug-resistant (MDR and XDR, respectively) tuberculosis (TB). To use these drugs effectively, drug susceptibility... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the QuantaMatrix Multiplexed Assay Platform for Molecular Diagnosis of Multidrug- and Extensively Drug-Resistant Tuberculosis Using Clinical Strains Isolated in Myanmar
-
Chang Y, Kim S, Kim Y, Ei PW, Hwang D, Lee J, Chang CL, Lee H
- KMID: 2460911
- Ann Lab Med.
- 2020 Mar;40(2):142-147.
- doi: 10.3343/alm.2020.40.2.142
BACKGROUND: Although the incidence of tuberculosis (TB) is decreasing, cases of multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB continue to increase. As conventional phenotype drug susceptibility testing (pDST) takes... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and treatment of multidrug-resistant tuberculosis
-
Kang YA
- KMID: 2194831
- J Korean Med Assoc.
- 2014 Jan;57(1):27-33.
- doi: 10.5124/jkma.2014.57.1.27
Multidrug-resistant tuberculosis (MDR-TB) is a great public health concern worldwide. MDR-TB denotes bacillary resistance to at least isoniazid and rifampicin. Extensively drug-resistant tuberculosis (XDR-TB) is MDR-TB with additional bacillary resistance... -
- CITED
-
- Close
- SHARE
-
- Close
- Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014
-
Tasbiti AH, Yari S, Ghanei M, Shokrgozar MA, Fateh A, Bahrmand A
- KMID: 2385157
- Osong Public Health Res Perspect.
- 2017 Apr;8(2):116-123.
- doi: 10.24171/j.phrp.2017.8.2.03
OBJECTIVES: Extensively drug-resistant tuberculosis (XDR-TB) is more expensive and difficult to treat than multidrug-resistant tuberculosis (MDR-TB), and outcomes for patients are much worse; therefore, it is important that clinicians understand... -
- CITED
-
- Close
- SHARE
-
- Close
- The Recent Status of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea
-
Kim SY, Kim HJ, Kim CK, Yoon HR, Bae HG, Lee SH, Sung N, Kim DY, Lee GY, Cho YS, Lee SD, Kim WS, Kim DS, Shim TS
- KMID: 1728959
- Tuberc Respir Dis.
- 2010 Mar;68(3):146-154.
- doi: 10.4046/trd.2010.68.3.146
BACKGROUND: The increasing incidence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) has become a serious worldwide problem. However, there is insufficient data regarding the current status of MDR-TB... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug resistance of Mycobacterium tuberculosis in children
-
Lee SJ, Ahn YM, Kim HJ
- KMID: 2037338
- Korean J Pediatr.
- 2009 Jan;52(1):61-67.
- doi: 10.3345/kjp.2009.52.1.61
PURPOSE: The rate of drug-resistant tuberculosis (DR-TB) in children is an indicator of the effectiveness of TB control programs in the community. This study aimed to assess the prevalence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center
-
Lee HY, Lee J, Lee YS, Kim MY, Lee HK, Lee YM, Shin JH, Ko Y
- KMID: 2160705
- Korean J Intern Med.
- 2015 May;30(3):325-334.
- doi: 10.3904/kjim.2015.30.3.325
BACKGROUND/AIMS: We evaluated the trend in the rates of drug-resistant tuberculosis (TB) over time, as well as the difference in the drug-resistance pattern between pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Clinical Characteristics between Pulmonary Tuberculosis Patients with Extensively Drug-resistance and Multi-drug Resistance at National Medical Center in Korea
-
Kim CK, Song HD, Cho DI, Yoo NS
- KMID: 2319035
- Tuberc Respir Dis.
- 2008 Jun;64(6):414-421.
BACKGROUND: Recently, in addition to multi-drug resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB) has become rapidly growing public health threat. This study examined the clinical differences between pulmonary TB patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Tuberculosis Drug Resistant Rates in Mycobacterium tuberculosis Isolated from Respiratory Specimens: A Multicenter Study in Korea
-
Kim J, Park YJ, Lee NY, Chang CL, Lee M, Shin JH
- KMID: 2169595
- Ann Clin Microbiol.
- 2013 Mar;16(1):1-7.
- doi: 10.5145/ACM.2013.16.1.1
BACKGROUND: We analyzed the prevalence of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates from respiratory specimens of patients with newly diagnosed and previously treated tuberculosis. METHODS: From February 2010 to July... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes and Prognostic Factors in Patients with Multidrug-Resistant Tuberculosis in Korean Private Hospitals
-
Park JK, Koh WJ, Kim DK, Kim EK, Kim YI, Kim HJ, Kim TH, Kim JY, Park MS, Park IN, Park JS, Lee KM, Song SH, Lee JH, Lee SH, Lee HP, Yim JJ, Lim J, Jegal YJ, Jung KH, Huh JW, Choi JC, Shim TS
- KMID: 2319373
- Tuberc Respir Dis.
- 2010 Aug;69(2):95-102.
BACKGROUND: The increasing rate of drug-resistant tuberculosis (TB) is a threat to the public health and TB control. In Korea, about 75~80% of TB patients are treated in private hospitals... -
- CITED
-
- Close
- SHARE
-
- Close
- Performance of the BacT Alert 3D System Versus Solid Media for Recovery and Drug Susceptibility Testing of Mycobacterium tuberculosis in a Tertiary Hospital in Korea
-
Kim SC, Jeon BY, Kim JS, Choi IH, Kim J, Woo J, Kim S, Lee HW, Sezim M, Cho SN
- KMID: 2365320
- Tuberc Respir Dis.
- 2016 Oct;79(4):282-288.
- doi: 10.4046/trd.2016.79.4.282
BACKGROUND: Tuberculosis (TB) is a major health problem, and accurate and rapid diagnosis of multidrug-resistant (MDR) and extended drug-resistant (XDR) TB is important for appropriate treatment. In this study, performances... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
-
Lee J, Lee CH, Kim DK, Yoon HI, Kim JY, Lee SM, Yang SC, Lee JH, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Yim JJ
- KMID: 1776587
- Korean J Intern Med.
- 2011 Jun;26(2):153-159.
- doi: 10.3904/kjim.2011.26.2.153
BACKGROUND/AIMS: To compare the effect of levofloxacin and moxifloxacin on treatment outcomes among patients with multidrug-resistant tuberculosis (MDR-TB). METHODS: A retrospective analysis of 171 patients with MDR-TB receiving either levofloxacin or... -
- CITED
-
- Close
- SHARE
-
- Close
